CompletedPhase 2NCT00503035

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

Studying Familial adenomatous polyposis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
M.D. Anderson Cancer Center
Principal Investigator
Imad Shureiqi, MD, D.M.D
M.D. Anderson Cancer Center
Intervention
Celecoxib(drug)
Enrollment
51 enrolled
Eligibility
16 years · All sexes
Timeline
20032021

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00503035 on ClinicalTrials.gov

Other trials for Familial adenomatous polyposis

Additional recruiting or active studies for the same condition.

See all trials for Familial adenomatous polyposis

← Back to all trials